1. Home
  2. STRO vs REAL Comparison

STRO vs REAL Comparison

Compare STRO & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$10.75

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$16.24

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRO
REAL
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
85.0M
1.7B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
STRO
REAL
Price
$10.75
$16.24
Analyst Decision
Hold
Buy
Analyst Count
8
8
Target Price
$18.29
$15.29
AVG Volume (30 Days)
123.2K
2.7M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$105,646,000.00
$662,789,000.00
Revenue This Year
$63.08
$17.10
Revenue Next Year
N/A
$10.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.30
52 Week Low
$5.23
$4.61
52 Week High
$21.50
$16.24

Technical Indicators

Market Signals
Indicator
STRO
REAL
Relative Strength Index (RSI) 81.15 68.97
Support Level $8.49 $15.13
Resistance Level $11.09 $16.08
Average True Range (ATR) 0.83 0.78
MACD 0.03 0.10
Stochastic Oscillator 89.41 96.11

Price Performance

Historical Comparison
STRO
REAL

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.

Share on Social Networks: